Table 7: Cumulative recurrent PAF* at the end of follow-up in the second investigation.

Groups (case number) Male Female
Total numberCumulative recurrent PAFTotal numberCumulative recurrent PAF

WK* treatment (54 cases)270271
Sotalol treatment (54 cases)272270
Control (55 cases)354205

value ( value6.886 (0.009)
value ( value4.813 (0.028)
value ( value0.343 (0.558)

WK: Wenxin Keli; PAF: paroxysmal atrial fibrillation; **analyzed by test.